GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Total Operating Expense

Glycorex Transplantation AB (NGM:GTAB B) Total Operating Expense : kr38.30 Mil (TTM As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Total Operating Expense?

Glycorex Transplantation AB's Total Operating Expense for the three months ended in Mar. 2025 was kr9.86 Mil. Glycorex Transplantation AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr38.30 Mil.

Glycorex Transplantation AB Total Operating Expense Historical Data

The historical data trend for Glycorex Transplantation AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Total Operating Expense Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.38 36.75 39.96 44.74 38.67

Glycorex Transplantation AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.23 9.47 8.51 10.45 9.86

Glycorex Transplantation AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr38.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glycorex Transplantation AB Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Glycorex Transplantation AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Total Operating Expense
Comparable Companies
OSTO:ISOFOL OSTO:ALZ OSTO:MVIR OSTO:BIOSGN XSAT:ABERA OSTO:INIT XSAT:BIOWKS XSAT:CURAS OSTO:KAN OSTO:ALZCUR VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
O33:Germany
Address
Solvegatan 41, Lund, SWE, 223 70
Website
http://www.glycorex.se
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines